Top Markets
Coin of the day
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Pozycja w akcjach #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
Cena akcji
$20.65
Ostatnia synchronizacja: 2023-03-01
Kapitalizacja rynkowa
$82.52M
Zmiana (1 dzień)
-0.58%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Opiant Pharmaceuticals, Inc. (OPNT)

Kategoria

Historia stopy dywidendy dla Opiant Pharmaceuticals, Inc. (OPNT)
Stopa dywidendy (TTM) dla Opiant Pharmaceuticals, Inc. (symbol akcji: OPNT) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Opiant Pharmaceuticals, Inc. (OPNT) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji